DT
PT
Subscribe To Print Edition About The Tribune Code Of Ethics Download App Advertise with us Classifieds
search-icon-img
search-icon-img
Advertisement

Scientists to probe if grape juice chemical can prevent bowel cancer

A team of scientists from UK is to set to probe a chemical called resveratrol, naturally occurring in grapes, blueberries, raspberries and peanuts, for potential cancer prevention
  • fb
  • twitter
  • whatsapp
  • whatsapp
featured-img featured-img
Photo for representation. iStock photo
Advertisement

UK scientists are launching a trial to explore whether an ingredient commonly found in grape juice and wine could keep bowel cancer at bay.

Bowel cancer, also known as colorectal cancer, is a type of cancer that starts in the large bowel, including the colon and rectum.

The team would probe a chemical called resveratrol -- a naturally occurring ingredient found in grapes, blueberries, raspberries and peanuts -- for potential cancer prevention.

Advertisement

The trial, led by researchers at the University of Leicester, UK, is also testing multiple potential prevention drugs for bowel cancer, including aspirin and metformin.

While drinking red wine does not prevent cancer and is a major risk factor, the research focussed on purified resveratrol.

Advertisement

Karen Brown, Professor of Translational Cancer Research at the University of Leicester said that with advanced screening methods, early detection of bowel cancer has become easier. She further noted that the best way to prevent bowel cancer “is to improve our lifestyles -- stopping smoking, maintaining a healthy weight, reducing alcohol consumption and having a healthy, balanced diet”.

However, with the new trial, funded by Cancer Research UK, the team aims to conduct a “unique experiment to see how drugs could stop bowel polyps from growing”.

Brown said the results can have wider “implications for how we prevent bowel cancer in people who are most likely to develop the disease as they get older.”

The team aims to enroll 1,300 patients at 60 locations in England and Wales.

If the trial is successful, any of the treatments tested could be offered to people eligible for the NHS Bowel Screening Programme to reduce the chance of bowel polyps forming, and with that reduce the risk of bowel cancer in the future.

Advertisement
Advertisement
Advertisement
Advertisement
tlbr_img1 Home tlbr_img2 Opinion tlbr_img3 Classifieds tlbr_img4 Videos tlbr_img5 E-Paper